Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: An in vitro co-culture study by Chai, J et al.
Title
Excessive ovarian stimulation up-regulates the Wnt-signaling
molecule DKK1 in human endometrium and may affect
implantation: An in vitro co-culture study
Author(s) Liu, Y; Kodithuwakku, SP; Ng, PY; Chai, J; Ng, EHY; Yeung,WSB; Ho, PC; Lee, KF
Citation Human Reproduction, 2010, v. 25 n. 2, p. 479-490
Issued Date 2010
URL http://hdl.handle.net/10722/135628
Rights
This is a pre-copy-editing, author-produced PDF of an article
accepted for publication in Human Reproduction following peer
review. The definitive publisher-authenticated version Human
Reproduction, 2010, v. 25 n. 2, p. 479-490  is available online at:
http://humrep.oxfordjournals.org/content/25/2/479
1 
Excessive Ovarian Stimulation up-regulates DKK1 of Wnt-signaling 
Pathway in Human endometrium affects Implantation: An in vitro 
Co-culture study 
 
Yunao Liu1, Suranga P Kodithuwakku1,2, Pak-Yiu Ng1, Joyce Chai1, Ernest H.Y. Ng1,3, 5 
William S.B. Yeung1,3, Pak-Chung Ho1,3, Kai-Fai Lee1,3 
 
1Department of Obstetrics and Gynaecology, Li Ka Shing Faculty of Medicine, The 
University of Hong Kong, Pokfulam, Hong Kong, CHINA 
2Department of Animal Science, The University of Peradeniya, Peradeniya, 20400, Sri Lanka 10 
3Center for Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The 
University of Hong Kong, Pokfulam, Hong Kong, CHINA 
 
The first-two authors contributed equally to this work.  This work was supported in part by 
grants from the Committee on Research and Conference Grant, The University of Hong 15 
Kong to KF Lee and Hong Kong Research Grant Council to PC Ho (HKU7514/05M). 
 
Address all correspondence and requests for reprints to: Kai-Fai Lee, PhD, Department of 
Obstetrics and Gynaecology, The University of Hong Kong, Pokfulam, Hong Kong. E-mail: 
ckflee@hkucc.hku.hk. 20 
 
Short title: Wnt-signaling molecules in endometrium 
Abbreviations: hCG, human chorionic gonadotrophin; HMG, human menopausal 
gonadotrophin; IVF, in vitro fertilization; LH, luteinizing hormone.
2 
Abstract 
BACKGROUND: High serum estradiol levels following ovarian stimulation affects 
endometrial development and gene expression profiles leading to reduced implantation and 
pregnancy rates.  Yet, the underlying molecular mechanism leading to these changes 
remains unknown. Accumulating data suggested that aberrant expression of a number of 5 
genes in the Wnt-signaling pathway may be involved in these processes.  
METHODS: In this study, microarray and real-time PCR analysis were performed to 
analyze the gene expression profile of endometrial samples taken at hCG+7 in stimulated 
cycles and LH+10 in the natural cycles and the expression of several Wnt-signaling 
transcripts including DKK1, DKK2 and sFRP4 were analyzed throughout the menstrual 10 
cycle.  The JAr spheroid-endometrial cells co-culture experiment was established to study 
the effect of DKK1 on spheroid attachment in vitro.  
RESULTS: Endometrial samples taken at hCG+7 in stimulated cycle shared similar gene 
expression profiles at LH+10 in the natural cycle.  The transcripts of several Wnt-signaling 
molecules including DKK1, DKK2 and sFRP4 were aberrantly expressed in the stimulated 15 
cycles. Treatment of spheroid with recombinant human DKK-1 protein dose-dependently 
suppressed spheroid attachment onto the endometrial Ishikawa cell line.  The suppressive 
effect of recombinant DKK-1 protein was nullified with the anti-DKK1 antibody; while the 
anti-DKK1 antibody alone had no effect on spheroid attachment. Furthermore, the decrease 
in spheroid attachment was associated with down-regulation of β-catenin expression in the 20 
DKK-1 treated JAr cells.  
CONCLUSION: High serum estradiol and/or progesterone concentrations advanced the 
gene expression profiles of peri-implantation endometrium in patients following ovarian 
stimulation. Aberrant expression of the Wnt-signaling molecule might impair embryo 
attachment and implantation in vivo.25 
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Introduction 
In vitro fertilization (IVF) is an effective treatment for various causes of infertility. 
Ovarian stimulation is used in a majority of assisted reproduction units in order to improve 
the pregnancy rate by increasing the number of oocytes and thus embryos available for 
transfer.  Recruitment and development of multiple follicles in response to gonadotrophin 5 
stimulation is a key factor leading to successful IVF treatment.  Gonadotrophin releasing 
hormone agonists are commonly used during ovarian stimulation to prevent a premature 
luteinizing hormone (LH) surge.  Several recent studies have compared the endometrial 
gene expression profiles in the luteal phase of natural and controlled ovarian stimulated 
cycles (Mirkin et al., 2004; Horcajadas et al., 2005; 2008; Simon et al., 2005, Macklon et al., 10 
2008; Liu et al., 2008; Haouzi et al., 2009a).  Yet, only a few differentially expressed genes 
were found in these studies, suggesting that the current controlled ovarian stimulation 
protocols could induce similar endometrial responses as those in natural cycles.  Excessive 
ovarian responses, however, may lead to an increased risk of ovarian hyperstimulation 
syndrome (OHSS) and adverse outcomes in IVF treatment (Simon et al., 1995; 1998; Pellicer 15 
et al., 1996; Ng et al., 2000; Macklon and Fauser, 2000).  We previously reported that 
women with serum E2 concentration on the day of hCG administration >20,000 pmol/L were 
associated with decreased implantation and pregnancy rates in IVF cycles (Ng et al., 2000).  
These excessive response cases have dys-synchronous development of the endometrium with 
delayed glandular maturation and advanced stromal morphology as determined by 20 
endometrial morphometric analysis (Basir et al., 2001).  They also have a significantly 
higher endometrial vascularity on day 7 after injection of human chorionic gonadotrophin 
(hCG+7) (Ng et al., 2004) and a discrete mRNA expression profile (Liu et al., 2008) when 
compared to those with lower E2 levels.  Yet, the embryo (Ng et al., 2000) and oocyte (Ng et 
al., 2003) quality is not affected by the high serum E2 level. 25 
4 
Implantation is a critical step in the establishment of a pregnancy.  There are a few 
studies (Carson et al., 2002; Kao et al., 2002; Borthwick et al., 2003; Riesewijk et al., 2003; 
Mirkin et al., 2005; Talbi et al., 2006; Haouzi et al., 2009b; Tseng et al., 2009) comparing the 
gene expression profiles of endometria during the implantation window with those in the 
proliferative or early luteal phases of the cycle.  In each of these studies, differential 5 
expression of a large number of genes was found.  However, only a few of these 
differentially expressed genes were common in most of these studies, indicating the 
complexity and variability of endometrial development (Horcajadas et al., 2004; Mirkin et al., 
2005). 
The Wnt-signaling pathway is crucial to estrogen-mediated uterine growth (Hou et al., 10 
2004) and implantation (Mohamed et al., 2005; Xie et al., 2008) in mice.  Dickkopf 
homolog 1 (DKK1) is a Wnt-signaling antagonist (Kawano et al., 2003) which is 
up-regulated in the implantation window (Kao et al., 2002; Tulac et al., 2003).  It is 
expressed in preimplantation embryos and the stromal cells of the mouse uterus (Li et al., 
2008).  Injection of DKK1 antisense oligonucleotide into the mouse uterine horns on day 3 15 
of a pregnancy inhibits embryo implantation (Li et al., 2008).  DKK1 secreted from 
decidual cells also plays a role in trophoblast cell invasion and outgrowth (Peng et al., 2008).  
Yet, mice deficient in DKK1 died at birth with morphological defects including lack of 
anterior head structures and duplications and fusions of the limb digits (Mukhopadhyay et al., 
2001). 20 
Our previous microarray data showed that the endometrial gene expression profile on 
hCG+7 in women with excessive response was different to that of natural cycling women on 
Day 7 after a LH surge (LH+7), and that the former group of women had aberrant expression 
of Wnt-signaling molecules (Liu et al., 2008).  However, the effects of super-physiological 
concentration of the steroid hormone on endometrial development at molecular level remain 25 
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unknown.  In this study, the expression of Wnt-signaling molecules (e.g. DKK1, DKK2 and 
sFRP4) in the human endometrium from patients receiving IVF treatment was examined and 
compared with the endometrial gene expression profiles of patients from the natural (LH+7 
and LH+10) and stimulated cycle (hCG+7).  Furthermore, the role of Dkk-1 on embryo 
attachment was analyzed using a spheroid-endometrial co-culture model. 5 
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Materials and Methods 
 
Human Subjects 
Thirty-seven infertile women (median = 33, range = 27 to 39 year) undergoing IVF 
treatment at the Assisted Reproduction Unit at the Department of Obstetrics and 5 
Gynaecology, Queen Mary Hospital, Hong Kong were recruited for the study.  They had 
regular menstrual cycles, normal uterus and no significant intra-uterine or ovarian 
abnormalities as determined by transvaginal ultrasonography. Only women with regular 
menstrual cycles and male factor infertility who had not received any steroidal hormones for 
two months or more prior to the study and also agreed to the use of condoms for 10 
contraception during the study cycle were recruited for endometrial biopsies in the natural 
cycles.  Another 45 human endometrial biopsies were taken from patients who visited our 
IVF clinic for infertility treatment.  The samples were taken in different phases of the 
menstrual cycle including early-/mid-proliferate phase (EPMP, n=8), late proliferate phase 
(LP, n=8), early secretory phase (ES, n=8), middle secretory phase (MS, n=15) and late 15 
secretory phase (LS, n=6).  They had no significant differences (p<0.05) in terms of age and 
duration of infertility.  Informed written consent prior to participation in the study was 
obtained, and was approved by the Institutional Review Board of the University of Hong 
Kong and Hospital Authority Hong Kong, West Cluster. 
 20 
Tissue Collection 
Endometrial biopsies were taken either on LH+7 or LH +10 from 21 patients in natural 
cycles.  Blood was taken daily for serum E2 and LH concentration, starting 18 days before 
the next expected menstruation until LH surge, which was defined as the day when the serum 
LH level was more than double the mean of the preceding readings.  For the stimulated 25 
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cycles, the subjects were recruited from those who did not have embryo transfer after IVF 
treatment because of either failure of fertilization or risk of OHSS.  Ovarian stimulations 
were carried out as described previously using the long protocol (Ng et al., 2000).  Briefly, 
the subjects were pretreated with gonadotrophin-releasing hormone analogue, buserelin 
(Suprecur, Hoechst, Frankfurt, Germany) nasal spray 150 μg four times a day from the 5 
mid-luteal phase of the cycle proceeding the treatment cycle.  The human menopausal 
gonadotrophin (HMG, Menogon, Ferring GmbH, Kiel, Germany) injection was administered 
after confirmation of pituitary down-regulation.  Human chorionic gonadotrophin (Profasi, 
Serono, Geneva, Switzerland) 10,000 IU was administered when the leading follicle reached 
18 mm in diameter and there were at least three follicles >15 mm in diameter.  Serum E2 10 
concentration was measured on the day of the ovulatory hCG injection and the patients were 
classified into either moderate (serum E2 ≤ 20,000 pmol/L) or excessive (serum E2 > 
20,000pmol/L) responders as described previously (Ng et al., 2000). 
 
RNA isolation and real-time PCR 15 
Total RNA from endometrial samples was purified using the Absolutely RNA RT-PCR 
miniprep kit (Stratagene, La Jolla, CA, USA) as described previously (Lee et al, 2006).  
One microgram of total RNA was reverse transcribed using the First strand cDNA synthesis 
kit (Amersham, Uppsala, Sweden).  The cDNA product was diluted with distilled water to a 
final volume of 50 μl. Real-time PCR was performed in an iCycler (Bio-Rad, Hercules, CA) 20 
as described (Lee et al., 2005).  Primers were designed using Primer Premier v5.0 (Premier 
Biosoft International, Palo Alto, CA).  All real-time PCR assays were performed with 
TaqMan PCR Master Mix (Applied BioSystems, Warrington, UK).  A standard PCR cycling 
protocol was performed: 1 cycle at 95ºC for 10 minutes; 40 cycles at 95ºC for 15 seconds, 
60ºC for 35 seconds and 72ºC for 45 seconds. The 2–ΔΔCT relative quantification method was 25 
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performed to analyze the data from real-time PCR experiment as described before (Livak and 
Schmittgen, 2001).  The house-keeping 18S gene was chosen as the internal control for 
sample normalization. 
 
RNA Isolation and Affymetrix Microarray 5 
Total RNA from 38 samples were isolated using the RNeasy Mini Kit (Qiagen, 
Crawley, Sussex, UK) according to the supplier’s protocol.  The total RNA bound to the 
column was eluted in RNase-free water. RNA quality control, sample labeling, GeneChip 
hybridization and data acquisition were performed at the Genome Research Centre, The 
University of Hong Kong.  In brief, the quality of total RNA of 7 endometrial samples from 10 
natural cycling women (LH+7, n=3; LH+10, n=4) and 3 endometrial samples on Day hCG+7 
from women with excessive response (hCG+7(E), n=3) was checked by an Agilent 2100 
bioanalyzer (Waldboronn, Germany).  The RNA was then amplified and labeled with the 
MessageAmp II-Biotin Enhanced Single Round cRNA Amplification Kit (Ambion Inc., 
Texas).  Double-stranded cDNA was generated by reverse transcription from 1 µg total 15 
RNA with an oligo(dT) primer bearing a T7 promoter.  The double strand cDNA was used 
as a template for in vitro transcription to generate biotin-labeled cRNA.  After 
fragmentation, 15 µg of cRNA was hybridized to the GenChips HG_U133A microarray 
(Affymetrix Inc., Santa Clara, CA) which composed of more than 22,000 probe sets that 
analyzed over 18,000 human transcripts and variants.  The GeneChips were washed and 20 
stained using the GeneChip Fluidics Station 450 (Affymetrix Inc.) and then scanned with the 
GeneChip Scanner 3000 7G (Affymetrix Inc.). 
 
Microarray Analysis 
GeneSpring 7.2 software (Agilent Technologies, Palo Alto, CA, USA) was used to 25 
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analyze the microarray data.  Per-Chip normalization was carried out first with the Robust 
Multi-chip Average (RMA) analysis algorithm based on the expression values of all genes.  
After RMA preprocessor analysis, the expression values on each microarray chip were 
normalized to the 50th percentile, and all the positive data were returned.  The Per-Gene 
normalization was performed next.  The expression values of each gene on all microarray 5 
chips were normalized to the median, and the cutoff value was set as 0.05. Genes with 
expression values lower than the cutoff were not analyzed further. 
The normalized expression values of all genes were first statistically analyzed by One 
Way ANOVA with the p-value set at 0.05 or less.  Genes that were differentially expressed 
(p<0.05, One Way ANOVA) between sample sets were identified.  The genes with ≥2-fold 10 
difference in pair-wise comparisons among LH+7 day and LH+10 day in natural cycles and 
hCG+7 day of excessive responders in stimulated cycles were selected. 
All differentially expressed genes (≥2-fold and p<0.05) were represented in a Venn 
diagram as up- and down-regulated genes.  Each differentially expressed gene was 
individually annotated with GeneCards terms (http://thr.cit.nih.gov/cards/index.shtml) and 15 
GeneSpring Gene Ontology (GO) annotations for categorizing into functional groups.  
Principal component analysis (PCA) was performed to detect variable components in all 10 
samples based on the normalized microarray data of all genes.  The two principal variable 
components with largest values were selected to generate a two-dimension scatter plot to 
visualize the difference in gene expression profiles between samples. 20 
Unsupervised clustering was employed to analyze the difference in gene expression 
profiles among 10 samples based on the normalized microarray data of all genes.  Ten 
samples were clustered into subgroups according to their similarity in the gene expression 
profile.  Differentially expressed genes were separated and clustered into up-regulated and 
down-regulated groups. 25 
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Western blotting 
Proteins form the spheroid and Ishikawa cells were extracted with RIPA buffer (1 ml) 
containing protease inhibitor and the mixtures were then centrifuged at 10,000 g for 10 min 
to remove the cell debris as described (Lee et al., 2008). The supernatants were collected and 5 
denatured at 95°C for 5 min in 1X SDS loading buffer. After boiling, the samples were 
resolved in 12% SDS-PAGE and were subjected to Western blotting. Antibodies against 
β-catenin (1:5000, BD Transduction Laboratory), GSK3-β (1:1000, BD Transduction 
Laboratory) and b-actin (1:5000, Sigma) were obtained from different commercial sources.  
Horseradish peroxidase conjugated goat anti-rabbit IgG secondary antibody (1:5000, GE 10 
Healthcare) was used, and specific signal was visualized by the enhanced chemiluminescence 
(ECL) method. 
 
Spheroid-endometrial cell attachment assay 
Choriocarcinoma cell (JAr, ATCC HTB-144) and endometrial adenomcarcinoma 15 
(Ishikawa, ECACC 99040201) were cultured at 37oC in a humid atmosphere with 5% CO2. 
JAr cells were maintained in RPMI 1640 (Sigma), supplemented with 10% fetal bovine 
serum (FBS, Invitrogen, Carlsbad, CA), 2 mM L-glutamine and penicillin/streptomycin (100 
U/ml and 0.1 mg/ml, Gibco).  Minimal essential medium (MEM, Sigma) supplemented with 
10% FBS, L-glutamine and penicillin/streptomycin was used for Ishikawa cells.  Adhesion 20 
of the choriocarcinoma cells to endometrial cells was quantified using an adhesion assay as 
described (Hohn et al., 2000; Uchida et al., 2007) with modifications.  Briefly, JAr cells 
were cultured in RPMI 1640 medium with or without 10 µM dibutyryl-cAMP (dbcAMP), 5 
µM methotrexate (MTX), 0.1-10 µg/ml human recombinant DKK-1 (hrDKK-1) or 1 µg/ml 
bovine serum albumin (BSA) for 2 days. Anti-DKK1 antibody (5-fold excess) was used to 25 
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neutralize the hrDKK-1 protein at 4oC for 24 hours before being used for JAr treatment.  
Multi-cellular spheroids were generated by shaking the trypsinized cells at 70 rpm for 24 
hours.  The spheroids were transferred onto the surface of a confluent monolayer of an 
endometrial Ishikawa cell line.  The cultures were maintained in MEM medium with 
supplements for 1 hour at 37oC in a humidified atmosphere with 5% CO2.  Non-adherent 5 
spheroids were removed by centrifugation at low g-force (120 rpm) for 10 minutes.  
Attached spheroids were counted under a light microscope, and expressed as the percentage 
of the total number of spheroids used (% adhesion).  Photographs of cultures were taken 
with a Nikon Eclipse TE300 inverted microscope (Nikon, Japan). 
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Statistical analysis 
 All results were expressed as means ± S.E.M.  Statistical comparisons were performed 
by One Way Analysis of Variance (ANOVA) followed by the Student-Newman-Keuls or 
Mann-Whitney U test where appropriate.  A probability of p<0.05 was used to indicate a 
significant difference. 15 
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Results 
 
Changes of differentially expressed genes in menstrual cycle 
 Previously, we reported that excessive ovarian stimulation affected the expression of a 
number of genes in the implantation window when compared with the natural cycle. A 5 
number of genes were up-regulated such as AOX1, NNMT, GPx3 and PAEP/glycodelin; 
while others such as SLC26A2, MMP26, SLC7A4 and PTGS1/COX1 were down-regulated 
in the excessive responders of hCG+7 samples (hCG+7(E)) when compared with that in the 
LH+7 samples in the natural cycles.  The temporal expressions of the 8 differentially 
expressed genes above were further evaluated in this study using endometrial samples taken 10 
from different phases (early-, mid- and late-proliferative and secretory phases) of natural 
cycles.  The expressions of AOX1, NNMT, GPx3 and PAEP were high in the late-secretory 
(LS) phase of the menstrual cycle (Fig. 1A).  On the other hand, the expressions of 
SLC26A2, MMP26, SLC7A4 and PTGS1/COX1 were high in the mid-secretory (MS) phase 
but decreased in the late-secretory phase (Fig. 1B).  These observations suggest that ovarian 15 
stimulation advanced the gene expression profiles in patients with excessive ovarian 
responses. 
 
Demographic Data 
To confirm that excessive ovarian stimulation resulting in advanced endometrial gene 20 
expression, we compared the gene expression profiles of hCG+7(E) and LH+7 with that of 
LH+10.  The demographic data of the subjects are shown in Table 1.  No significant 
differences in age and duration of infertility were found between the three groups of subjects.  
The serum estradiol and progesterone concentrations in the stimulated group (hCG+7(E)) 
were significantly higher (p<0.05) than that of LH+7 and LH+10 groups in the natural cycles. 25 
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Microarray Analysis 
The total RNA from 10 endometrial samples (LH+7, LH+10 in natural cycles and 
hCG+7(E) in stimulated cycle) were extracted and subjected to Affymetrix HG_U133A 
analysis.  Gene clustering and principal component analyses (PCA) were used to group and 5 
generate the two-dimensional representations of the 10 samples based on their gene 
expression patterns (Fig. 2A and B).  Interestingly, two hCG+7(E) samples from the 
excessive responders and one LH+10 sample from natural cycling women were clustered 
together in one region, while the remaining one hCG+7(E) sample and three other LH+10 
samples were clustered in another region.  The three LH+7 samples were grouped together 10 
as a cluster distinct from the other samples (Fig. 2A), indicating that the endometrial gene 
expression profiles of hCG+7(E) samples were more similar to the LH+10 samples.  Similar 
findings were observed when PCA was performed (Fig. 2B). 
The number of genes that were differentially expressed in the endometrial samples 
among the three groups is summarized in the Vann diagrams (Fig. 2C and D).  Altogether, 15 
351 differentially expressed (259 up-regulated and 92 down-regulated) genes were identified.  
There were 146 up-regulated and 46 down-regulated genes identified in both hCG+7(E) and 
LH+10 samples when compared with the LH+7 samples.  The endometrial gene expression 
profiles in the LH+10 and the hCG+7(E) samples were very similar; only 5 up-regulated and 
3 down-regulated genes were identified (Fig. 2C and D).  Only 3 genes were found to be 20 
differentially up-regulated among the three groups of endometrial samples (Table 2). 
 
Differential expression of Wnt-signaling molecules in endometrial samples 
We previously reported aberrant expression of Wnt-signaling molecules including 
DKK1, DKK2 and sFRP4 in the endometria of excessive responders in microarray analysis 25 
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(Liu et al., 2008).  Real-time RT-PCR analysis of DKK1, DKK2 and sFRP4 confirmed that 
DKK1 was up-regulated and DKK2 and sFRP4 were down-regulated in the moderate 
(hCG+7-M, n=15) and excessive (hCG+7(E), n=17) responders of the stimulated cycle group 
when compared to patients in the natural (LH+7, n=15) group (Fig. 3).  Interestingly, the 
expression levels of DKK1, DKK2 and sFRP4 transcripts in LH+10 and hCG+7(E) were 5 
similar (Fig. 3).  The expression levels of the DKK1, DKK2 and sFRP4 proteins in the 
human endometria were studied by Western blotting.  DKK1 showed an up-regulation in 
protein expression in the stimulated (M and E) and LH+10 samples, but not for DKK2 and 
sFRP4 proteins. 
 10 
Expression of Wnt-signaling molecules in endometrium in menstrual cycle 
 The expression of five Wnt-signaling molecules including DKK1, DKK2, sFRP4, 
Wnt5B and FZD5 in human endometrial samples taken on early-/mid-proliferative (EP/MP), 
late-proliferative (LP), early-secretory (ES), mid-secretory (MS) and late-secretory (LS) 
phases were studied using real-time PCR (Fig. 4).  The expression of DKK1 transcript was 15 
low in the proliferative phase, but increased significantly in the late-secretory phase; while 
DKK2 transcript increased from the proliferative phase, peaked in the mid-secretory phase 
and decreased in the late-secretory phase.  On the other hand, the expression of sFRP4 was 
high in the proliferative phase, but was significantly down-regulated in the secretory phase of 
the cycle.  Interestingly, Wnt5B decreased from the proliferative phase to the mid-secreatory 20 
phase but increased significantly in the late-secretory phase of the cycle.  There was no 
significant change in the expression of FZD5 throughout the menstrual cycle. 
 
Wnt-signaling in Spheroid-endometrial cell attachment assay 
A spheroid-endometrial co-culture assay was used to study the effect of 25 
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Wnt-signaling molecules on attachment of trophoblast cells onto human endometrial cells in 
vitro.  The spheroid was generated by shaking the trypsinized JAr cells at 70 rpm for 24 hrs 
at 37oC.  JAr spheroid of diameters 60-300 µm were used for attachment of the JAr cells 
onto the endometrial Ishikawa cells (Figure 5A).  To select the most effective chemicals that 
inhibit spheroid attachment, we treated the JAr cells with 10 µM dbcAMP or 5 µM MTX 5 
before spheroid generation.  It was found that both dbcAMP and MTX suppressed the 
attachment of the spheroid onto endometrial Ishikawa cells effectively (Figure 5B). 
Treatment of JAr with recombinant human DKK-1 protein (rhDKK-1, 0.1-10 µg/ml) 
dose-dependently suppressed spheroid attachment onto Ishikawa cells (Figure 5C).  The 
percentage of attachment decreased from 69.2% to 43.5% at 0.1 to 10 µg/ml DKK-1 protein 10 
used.  The decrease in attachment was significantly different (p<0.05) from the control at a 
DKK-1 concentration of 0.1 to 10 µg/ml.  No significant change in attachment was 
observed when BSA was compared with the untreated control (82.8% vs 86.0 %, 
respectively).  In all the treatment groups, the average viability of JAr cells was 88-95% as 
determined by Trypan Blue staining (data not shown). 15 
The specific action of recombinant DKK-1 protein was further confirmed with 
anti-DKK1 antibody in the co-culture experiment.  Anti-DKK1 antibody (5-fold molar 
excess) successfully neutralized the inhibitory effect of rhDKK-1 protein from 64.1% to 
87.6% attachment rate of JAr spheroid (Figure 5D).  The anti-DKK1 antibody alone had no 
effect on JAr spheroid attachment when compared with the untreated control (93.0% vs 20 
95.7%).  It was observed that DKK-1 down-regulates β-catenin expression in the JAr 
spheroid (Fig. 5E), but not the Ishikawa cells (data not shown).  Interestingly, this inhibition 
was not mediated by an increased GSK-3β expression in the spheroid after DKK-1 treatment.
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Discussion 
Excessive ovarian stimulation in patients undergoing IVF treatment affects normal 
endometrial development and manifests as asynchronous stromal and epithelial cell 
maturation (Basir et al., 2001).  In line with our previous study, real-time PCR analysis 
confirmed advancement of gene expression patterns following ovarian stimulation in the 5 
excessive responders.  This was further confirmed by similar endometrial gene expression 
profiles between LH+10 and hCG+7(E) samples by microarray analysis.  Our previous 
study suggested that aberrant expression of Wnt-signaling molecules in hCG+7 samples (Liu 
et al., 2008) may alter the development of the endometrium and thereby lower the receptivity 
of patients. This in vitro functional study using a spheroid-endometrial cell co-culture model 10 
demonstrates that spheroid treated with a Wnt-signaling molecule (DKK1) lowered the 
attachment rate of JAr cells on Ishikawa cells when compared with untreated or BSA control. 
Patients receiving ovarian stimulation for IVF treatment have about 5% chance of 
developing OHSS (Delvigne and Rozenberg, 2002), which is manifested in terms of 
abdominal bloating, feeling of fullness, nausea and diarrhea.  Our previous clinical study 15 
showed that excessive ovarian stimulation was also associated with a significant reduction in 
the pregnancy rate (Ng et al., 2000) and abnormal endometrial development (Basir et al., 
2001). It is hypothesized that high serum estrogen and progesterone concentrations following 
excessive ovarian stimulation change the endometrial gene expression profiles (Liu et al., 
2008) resulting in advancement of endometrial development not conducive to embryo 20 
implantation.  Table 3 summarizes recent microarray studies on human endometrial 
receptivity between natural and stimulated cycles. By using real-time RT-PCR, we 
demonstrated that the mRNA expression of 4 genes (AOX1, NNMT, GPx3 and PAEP) 
up-regulated in excessive responders were high only in the late-secretory phase of a natural 
cycle, whereas that of another 4 genes down-regulated in excessive responders were low in 25 
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the late-secretory phase.  These observations suggest that excessive ovarian stimulation 
advanced endometrial development and shortened the implantation window for embryo 
attachment. 
This hypothesis was further supported by microarray analysis of 10 endometrial 
samples using gene clustering and PCA analyses.  Our data showed that the three hCG+7(E) 5 
samples and the four LH+10 samples were more closely related than the three LH+7 samples, 
demonstrating that the endometrial gene expression patterns of hCG+7(E) resembled that of 
the late-secretory phase (LH+10) in natural cycles, when the implantation window is about to 
be closed (Wilcox et al., 1999; Norwitz et al., 2001).  Therefore, it is speculated that 
excessive ovarian stimulation advances endometrial development which leads to early 10 
closure of the implantation window and therefore a decrease in the pregnancy rate.  In line 
with the speculation, endometrium taken on the day of oocyte retrieval after GnRH 
antagonist/rec-FSH cycles showed an advanced maturation for 2-3 days (Noyes’ criteria) for 
patients with pregnancies (Van Vaerenbergh et al., 2009).  On the other hand, a delay of 
gene expression was observed in endometria from leuprolide/HMG+FSH cycles and natural 15 
cycles. A delay of 2 days was found between samples collected on hCG+7 and on LH+7 
(Horcajadas et al., 2008).  The discrepancy of the results obtained from different studies 
could be due to differences in the stimulation protocols used (buserelin/HMG vs 
leuprolide/HMG+FSH) and in estrogen levels (≥20000 pmol/L vs unselected) of the recruited 
subjects. 20 
Our previous microarray analyses showed that DKK1 was up-regulated by >3-fold 
and DKK2 was down-regulated by >2-fold in excessive responders (Liu et al., 2008). These 
molecules regulate the canonical Wnt-signal pathway in Xenopus embryos (Wu et al., 2000). 
This pathway is critical for estrogen-mediated uterine growth (Hou et al., 2004) and 
implantation in mice (Mohamed et al., 2005, Xie et al., 2008). The Suppression of 25 
18 
Wnt-signaling pathway results in accumulation of phosphorylated β-catenin by active 
glycogen synthase kinase-3 and affects the implantation process (Mohamed et al., 2005). 
DKK1 is up-regulated in the human endometrium during the implantation window in 
natural cycles (Kao et al., 2002; Tulac et al., 2003).  Ovarian stimulation further increased 
DKK1, but suppressed DKK2 and sFRP4 expressions in our hCG+7(E) endometrial samples.  5 
The expression levels of these molecules were similar between hCG+7(E) and LH+10 
samples, suggesting that dys-regulation of Wnt-signaling molecules in hCG+7 samples might 
contribute to a sub-optimal environment for implantation.  In relation to this, the temporal 
changes of Wnt-signaling molecules (DKK1, DKK2, sFRP4, Wnt5B and FZD5) throughout 
the menstrual cycle confirmed our hypothesis that an advancement of endometrial gene 10 
expression patterns was found. 
Since the expression of DKK1 transcript and protein were significantly reduced in the 
stimulated and LH+10 samples, we further hypothesized that an aberrant increase of DKK1 
expression might affect embryo attachment, an initial step of implantation.  The hypothesis 
was tested by adding recombinant DKK1 in the JAr/spheroid-Ishikawa cell attachment 15 
experiment (Hohn et al., 2000).  The endometrial epithelial carcinoma cell line Ishikawa 
was selected as the model for receptive endometrium since the Ishikawa cells express various  
well known receptivity- and implantation-related molecules like integrins (Castelbaum et al., 
1997), cell surface, extra cellular matrix (ECM), and cell adhesion molecules (Hannan et al., 
in press), as well as estrogen and progesterone receptors (Nishida et al., 1985; Lessey et al., 20 
1996; Nishida et al., 1996; Nishida, 2002) responsible for hormonal stimulation. The 
trophoblastic choricarcinoma cell line JAr displays cytotrophoblstic characteristics (Apps et 
al., 2009) and an ability to attach to the Ishikawa cells in vitro (Heneweer et al. 2005).  
It was found that DKK1 dose-dependently inhibited the attachment process and that 
this inhibitory effect could be neutralized by anti-DKK1 antibody. Interestingly, DKK1 25 
19 
suppressed the attachment process associated with down-regulation of β-catenin expression 
in the spheroid but not the Ishikawa cells.  But, no observable changes in GSK-3β and 
β-actin expression were found.  Although results from the present co-culture study support 
the importance of Wnt-signaling on implantation, extrapolating these results to the in vivo 
context should be treated with caution. In fact, this and other in vitro co-culture models using 5 
human embryos or endometrial samples have their limitations including the limited 
availability of donated human embryos and variation in biological responses between 
patients’ samples (Teklenburg & Macklon 2009). Yet, inactivation of nuclear Wnt-β-catenin 
signaling limits blastocyst competency for implantation (Xie et al., 2008; Chen et al., 2009).  
Moreover, DKK1 secreted from decidual cells plays an important role in trophoblast cell 10 
invasion.  In line with this, ectoplacental cones migration was inhibited when DKK1 was 
suppressed by anti-sense DKK1 oligonucleotide but stimulated by anti-sense β-catenin 
oligonucleotide (Peng et al., 2008). 
Accumulating evidence suggest that Wnt-signaling plays a significant role during 
mouse pre-implantation development (Kemp et al., 2005, Lloyd et al., 2003, Mohamed et al., 15 
2004 , Na et al., 2007) and blastocyst activation (Mohamed et al., 2004; De Vries et al., 2004). 
It has also been showed that activation of Wnt-signaling in 293T cells itself increases the 
secretion of DKK-1 (Niida et al., 2004) to the medium providing a direct evidence for the 
presence of a feedback loop to regulate the Wnt- signaling activation at the cellular level.  
However, to definitively establish the existence of such feedback loop in endometrium and 20 
embryo further investigations are needed. 
In summary, high serum estradiol and/or progesterone concentrations affect the 
development and the gene expression profiles of peri-implantation endometrium in humans.  
Aberrant expression of Wnt-signaling molecules (e.g. DKK1) caused by high serum 
estradiol/progesterone levels may be associated with sub-optimal endometrial development 25 
20 
not conducive to embryo attachment in vivo.  Further functional studies on the differentially 
expressed genes using primary endometrial cells and human embryos may provide valuable 
insights to our understanding of endometrial receptivity and embryo implantation in vivo. 
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Figure Legend 
 
Figure 1 
Quantitative RT-PCR of differentially expressed genes in menstrual cycle. (A) Real-time 
RT-PCR analysis of AOX1, NNMT, GPx3 and PAEP/glycodelin genes which were 5 
up-regulated in hCG+7 samples and (B) real-time RT-PCR analysis of Slc26A2, MMP26, 
SLc7A4 and PTGS1/COX1 genes which were down-regulated in hCG+7 samples when 
compared with LH+7 samples.  The fold-change (mean ± S.E.M.) in the expression levels 
of these genes among the menstrual cycle at early proliferative (EP), mid-proliferative (MP), 
late-proliferative (LP), early-secretory (ES), mid-secretory (MS) and late-secretory (LS) were 10 
determined (n=3 to 5 samples).  
 
Figure 2 
Microarray analysis of human endometrial samples from LH+7, LH+10 and hCG+7. 
Normalized expression data of all genes in each microarray chip were used in the clustering 15 
and PCA analyses. (A) Hierarchical clustering analysis of 10 human endometrial samples 
taken from LH+7, LH+10 and hCG+7 (excessive responders with serum E2 > 20,000pmol/L 
on hCG day). The up-regulated (red) and down-regulated (green) genes (rows) of 10 
endometrial samples (columns) were clustered into 2 major groups. (B) Principal component 
analysis (PCA) was used to group samples with similar gene expression patterns. Two 20 
principal variables in the gene expression profile data were presented in a 2-dimension 
system between the natural cycles (●, LH+7; ○ LH+10) and excessive responders (▲, 
hCG+7) of stimulated cycles. The percentages of variances for the PCA1 and PCA2 were 
27.65% and 20.16%, respectively.  (C and D) Venn diagrams representation of differentially 
expressed genes in three groups of samples.  All differentially expressed genes (≥2-fold; one 25 
28 
way ANOVA, p<0.05) in pair-wise comparisons among the natural cycles (LH+7, LH+10) 
and excessive responder (hCG+7) of stimulated cycles were shown. Similar gene expression 
patterns found in multiple pair-wise comparisons were shown in the overlapped areas. Venn 
diagrams showed the (C) 259 up-regulated and (D) 92 down-regulated genes among the 3 
groups of samples. 5 
 
Figure 3 
Quantitative RT-PCR and Western blotting of differentially expressed genes in 
Wnt-signaling pathway. Real-time RT-PCR experiments were performed to analyze the 
gene expression patterns of three differentially expressed Wnt-signaling molecules (DKK1, 10 
DKK2 and sFRP4) in natural (LH+7 and LH+10), stimulated (hCG+7) samples (moderate 
and excessive responders, M and E, respectively).  The fold-change in the expression levels 
of these genes among natural cycle at LH+7 (LH+7, n=15 and LH+10, n=10), and stimulated 
samples (moderate, n=15 and excessive, n=17) were studied.  A value of one was set for the 
natural group (LH+7).  Representative Western blotting of DKK1, DKK2 and sFRP4 15 
proteins in the endometrial samples taken from natural cycle at LH+7, LH+10 and in the 
stimulated cycle at hCG+7 were shown at the bottom.  a-b denotes significant different at 
p<0.05. 
 
Figure 4 20 
The expression Wnt-signaling molecules Dkk-1, Dkk-2, sFRP4, Wnt5B and FZD5 in 
menstrual cycle.  Real-time RT-PCR analysis was performed on human endometrial 
biopsies at early-/mid-proliferate phase (EPMP, n=8), late-proliferate phase (LP, n=8), 
early-secretory phase (ES, n=8), mid-secretory phase (MS, n=15), late-secretory phase (LS, 
n=6). The fold-change (mean ± S.E.M.) of the gene is relative to EPMP which was arbitrary 25 
29 
set to 1. a-b, a-c and b-c denotes statistically different at p<0.05 by one way ANOVA. 
 
Figure 5 
Effect of DKK-1 treatment on in vitro attachment between JAr spheroids and Ishikawa 
cells.  (A) Spheroids of 60-200µm in size were prepared from JAr cells for co-culture study 5 
(left), and a spheroid was attached to Ishikawa monolayer (right) after 1 hour of co-culture.  
Scale bar = 100µm.  (B) Effect of 10µM dbcAMP and 5µM MTX on the attachment of 
spheroid onto Ishikawa cells.  (C) Effect of DKK-1 recombinant protein and BSA on the 
attachment of JAr spheroid onto endometrial Ishikawa cells.  The results were from 3 or 
more pooled experiments and the total number of spheroid used is 1022.  DKK-1 10 
dose-dependently suppressed JAr spheroid attachment from 0.1-10 µg/ml. BSA at 1 µg/ml 
did not suppress spheroid attachment under the same culture condition.  (D) Neutralization 
effect of DKK-1 antibody on JAr spheroid attachment.  DKK-1 antibody neutralized the 
suppressive effect of rhDKK-1 on spheroid attachment study. Different letter denotes 
significantly different (p<0.05) from the control by Mann-Whitney test. (E) Western blotting 15 
of JAr cells treated with DKK-1.  The expression of β-catenin, GSK-3β and β-actin proteins 
were shown.  
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TABLE 1 Demographic data of the 37 subjects 
 
          Natural cycle   Stimulated cycle 
Demographic data      LH+7  LH+10  hCG+7   p-value 
         (n=11)  (n=10)  (n=17) 5 
Age      31.9 ± 3.0 35.0 ± 1.8 32.6 ± 3.0  NS 
      (27, 36)  (33, 39)  (27, 38) 
Duration of infertility  6.3 ± 2.9  5.9 ± 3.7  5.1 ± 1.9   NS 
 (Years)    (3, 13)  (2, 15)  (2, 8) 
Estradiol on LH/hCG  789 ± 315a 1060 ± 317a 28367 ± 10096b p<0.001 10 
 day (pmol/L)   (442, 1313) (405, 1483) (20600, 61608) 
Estradiol on LH+7/+10     499 ± 266a 524 ± 158a 13222 ± 6833b  p<0.001 
 or hCG+7day (pmol/L) (263, 1046) (257, 673) (3536, 28900)  
Progesterone on LH +7/+10 55.7 ± 26.2 a 63.8 ± 19.6 a 792.8 ± 404.5 b p<0.001 
 or hCG+7 day (nmol/L) (11.3, 88.6) (29.2, 89.6) (184.8, 1161.3) 15 
HMG dosage    NA   NA   25.9 ± 6.9  NA 
 (ampoule)         (16, 45)  
HMG duration   NA   NA   9.8 ± 1.5   NA 
 (day)          (7, 13) 
Number of oocytes   NA   NA   23.9 ± 9.6  NA 20 
 aspirated           (10, 46) 
Number of oocytes   NA   NA   12.8 ±8.9   NA 
fertilized          (0, 29) 
Values are given as mean ± SD (range), NA: Not applicable; NS: Not significant. 
a-b denotes significant difference between groups. 25 
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TABLE 2 Genes that differentially expressed between three groups of samples (≥2-fold; 
one way ANOVA, p<0.05) by microarray analysis. 
 
 
 
Code 
 
 
Gene Name 
Fold change 
hCG+7 vs 
LH+7  
LH+10 vs 
LH+7 
Differentially up-regulated genes in 3 groups  
220196_at Mucin 16, cell surface associated / CA125 2.1 7.5 
212992_at AHNAK2 nucleoprotein 2 / C14orf78 2.8 5.7 
208161_s_at ATP-binding cassette, sub-family C (CFTR/MRP) 2.5 5.1 
 
hCG+7: hCG+7 day in the stimulated cycle; 5 
LH+7: LH+7 day in the natural cycle; 
LH+10: LH+10 day in the natural cycle. 
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TABLE 3  Recent microarray studies on human endometrial gene expression profiles 
 
Study First Day  Second Day (Sample number, Drug used) Fold change Gene Microarray Probe set 
 (Sample number)  (p-value) Up Down   
Natural Cycle        
Carson et al., 2002 LH+2~4 (n=3) LH+7~9 (n=3) ≥2 (<0.05) 323 370 HG-U95A  12,686 human genes and ESTs 
Kao et al., 2002 Proliferative phase (n=4) LH+8~10 (n=7) ≥2 (<0.05) 156 377 HG-U95A 12,686 human genes and ESTs 
Riesewijk et al., 2003 LH+2 (n=5) LH+7 (n=5) ≥3 (n/a) 153 58 HG-U95A 12,686 human genes and ESTs 
Mirkin et al., 2005 LH+3 (n=3) LH+8 (n=5) ≥2 (n/a) 49 58 HG-U95A 12,686 human genes and ESTs 
Talbi et al., 2006 Early Secretory phase (n=3) Mid-secretory phase (n=8) ≥1.5 (<0.05) 1415 1463 HG-U133 Plus 2.0 >47,000 transcripts 
Haouzi et al., 2009b LH+2 (n=31) LH+7 (n=31) ≥2 (0.05) 945 67 HG-U133 Plus 2.0 >47,000 transcripts 
Tseng et al., 2009 Mid-secretory phase (n=28) Late-secretory phase (n=28) n/a 126 n/a HG-U133 Plus 2.0 >47,000 transcripts 
Current Study LH+7 (n=4) LH+10 (n=3) ≥2 (<0.05) 182 70 HG-U133A >22,000 human DNA fragments 
Natural vs Stimulated cycle       
Mirkin et al., 2004 LH+8 (n=5) hCG+9 (n=5, Follistim/ganirelix/Gonal-F/cetrorelix, 
0.25 mg/day ) 
≥1.19 (n/a) 6 6 HG-U95Av2 12,686 human genes and ESTs 
 LH+8 (n=5) hCG+9 (n=5, Leuprolide acetate, 0.25~0.5 mg/day) ≥1.2 (n/a) 5 1   
Horcajadas et al., 2005 LH+7 (n=14) hCG+7 (n=5, Leuprolide acetate, 1mg/day) ≥3 (≤0.01) 281 277 HG-U133A >22,000 human DNA fragments 
Simon et al., 2005 LH+7 (n=14) hCG+7 (n=4, Ganirelix, 0.25 mg/day) ≥2 (n/a) 22 69 HG-U133A >22,000 human DNA fragments 
 LH+7 (n=14) hCG+7 (n=4, Ganirelix, 2 mg/day) ≥2 (n/a) 88 24   
 LH+7 (n=14) hCG+7 (n=4, Buserelin, 0.6mg/day) ≥2 (n/a) 22 100   
Macklon et al., 2008 LH+5 (n=4) hCG+5 (n=4, Orgalutran, 0.25mg/day) ≥2 (<0.05) 142 98 HG-U133 Plus 2.0 >47,000 transcripts 
Horcajadas et al., 2008 LH+7 (n=5) hCG+7 (n=5, Leuprolide acetate, 1mg/day) n/a (<0.01) 69 73 HG-U133A >22,000 human DNA fragments 
Liu et al., 2008 LH+7 (n=5) hCG+7 (n=8, Buserelin, 0.6mg/day) ≥2 (<0.01) 249 161 HG-U133A >22,000 human DNA fragments 
Haouzi et al., 2009a LH+2 (n=21) 
LH+7 (n=21) 
hCG+2 (n=21, n/a) 
hCG+5 (n=21, n/a) 
≥2 (<0.05) 
≥2 (<0.05) 
321 
657 
4 
0 
HG-U133 Plus 2.0 >47,000 transcripts 
Current Study LH+10 (n=4) hCG+7 (n=3, Buserelin 0.6mg/day) ≥2 (<0.05) 3 5 HG-U133A >22,000 human DNA fragments 
 
